Author Archives: april@madhedgefundtrader.com

The 2028 Patent Cliff And Other Fairy Tale

I remember sitting in a conference room at Merck’s (MRK) Kenilworth headquarters back in 2014, watching their presentations on some experimental cancer drug called pembrolizumab. Half the analysts in the room were checking their phones. That drug became Keytruda, now pulling in $32 billion annually, and those same analysts are convinced the company’s about to […]

Ride Share Tech Faltering

Ride-sharing tech is no longer in any type of growth phase, and the opportunities to profit are diminishing. This subsector is yet another example of the waning influence of tech stocks and another sign of why the Nasdaq has traded sideways for around the last 5 months. We are exhausting the short-term drivers, and at […]

Some Sage Advice About Asset Allocation

Asset allocation is the one question that I get every day, which I absolutely cannot answer. The reason is simple: no two investors are alike. The answer varies whether you are young or old, have $1,000 in the bank or $1 billion, are a sophisticated investor or an average Joe, in the top or the […]